The Top Five Biotech Innovations of the 2000s

Clay Siegall12/15/09

Share and Comment

4 Comments Order a Reprint E-mail this Story

• Share on Twitter
• Share on Facebook


• Share on Linkedin
• Share on Google
• Submit to Hacker News

[Editor's Note: As the decade comes to an end, we've asked a number of Xconomists around the country to weigh in with the Top 5 innovations they've seen in their respective fields the past 10 years, or the Top 5 disruptive technologies that will impact the next decade. Here's the first installment.]

Here are the 5 biotech innovations from this decade that are currently (or will be shortly) making a big difference for patients with a variety of diseases.

1) Cancer therapies such as Roche/Genentech’s trastuzumab (Herceptin) and Celgene’s lenalidomide (Revlimid).

2) HIV therapies such as Gilead Sciences’ combination of efavirenz, emtricitabine, and tenofovir (Atripla).

3) Improved flu vaccines.

4) Therapies for hepatitis C such as Vertex Pharmaceuticals’ telaprevir.

5) Tumor vaccines such as Dendreon’s sipuleucel-T (Provenge).

Clay Siegall co-founded Seattle Genetics in 1998 and is the company’s President, Chief Executive Officer and a member of the Board of Directors. Follow @